ROIV Earnings Roivant Sciences Ltd.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| FY 2025 | 2026-03-31 | -0.54 | 2026-05-20 | 10-K |
| Q3 2025 | 2025-12-31 | -0.88 | 2026-02-06 | 10-Q |
| Q2 2025 | 2025-09-30 | -0.49 | 2025-11-10 | 10-Q |
| Q1 2025 | 2025-06-30 | -0.33 | 2025-08-11 | 10-Q |
| FY 2025 | 2025-03-31 | -0.24 | 2026-05-20 | 10-K |
| Q3 2025 | 2024-12-31 | 0.05 | 2026-02-06 | 10-Q |
| Q2 2025 | 2024-09-30 | -0.18 | 2025-11-10 | 10-Q |
| Q1 2025 | 2024-06-30 | 0.12 | 2025-08-11 | 10-Q |
| FY 2025 | 2024-03-31 | 5.23 | 2026-05-20 | 10-K |
| Q3 2024 | 2023-12-31 | 5.46 | 2025-02-10 | 10-Q |
| Q2 2024 | 2023-09-30 | -0.78 | 2024-11-12 | 10-Q |
| Q1 2024 | 2023-06-30 | -0.38 | 2024-08-09 | 10-Q |
| FY 2024 | 2023-03-31 | -1.42 | 2025-05-29 | 10-K |
| Q3 2023 | 2022-12-31 | -1.39 | 2024-02-13 | 10-Q |
| Q2 2023 | 2022-09-30 | -0.89 | 2023-11-13 | 10-Q |
| Q1 2023 | 2022-06-30 | -0.48 | 2023-08-14 | 10-Q |
| FY 2023 | 2022-03-31 | -1.26 | 2023-06-28 | 10-K |
| Q3 2022 | 2021-12-31 | -0.87 | 2023-02-13 | 10-Q |
| Q2 2022 | 2021-09-30 | -0.45 | 2022-11-14 | 10-Q |
| Q1 2022 | 2021-06-30 | -0.13 | 2022-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.